The molecular mechanism underlying MKP-1-mediated resistance to anti-cancer drugs is in part due to the activation of JNK-driven apoptosis by several anti-tumour agents such as anthracyclines, taxanes, cisplatin, proteasome inhibitors and more recently anti-EGFR drugs. This evidence concerns the gene DUSP1 and cancer.